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Abstract
Enteropathogenic bacteria are a frequent cause of diarrhea worldwide. The mucosal defenses against infection are not
completely understood. We have used the streptomycin mouse model for Salmonella Typhimurium diarrhea to analyze the
role of interferon gamma receptor (IFN-cR)-signaling in mucosal defense. IFN-c is known to contribute to acute S.
Typhimurium diarrhea. We have compared the acute mucosal inflammation in IFN-cR
-/- mice and wild type animals. IFN-cR
-/-
mice harbored increased pathogen loads in the mucosal epithelium and the lamina propria. Surprisingly, the epithelium of
the IFN-cR
-/- mice did not show the dramatic ‘‘loss’’ of mucus-filled goblet cell vacuoles, a hallmark of the wild type mucosal
infection. Using bone marrow chimeric mice we established that IFN-cR-signaling in stromal cells (e.g. goblet cells,
enterocytes) controlled mucus excretion/vacuole loss by goblet cells. In contrast, IFN-cR-signaling in bone marrow-derived
cells (e.g. macrophages, DCs, PMNs) was required for restricting pathogen growth in the gut tissue. Thus IFN-cR-signaling
influences different mucosal responses to infection, including not only pathogen restriction in the lamina propria, but, as
shown here, also goblet cell function.
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Introduction
Salmonella enterica subspecies 1 serovar Typhimurium (S.
Typhimurium) is a frequent foodborne pathogen worldwide [1].
Via virulence factors, encoded on Salmonella Pathogenicity Island
1, S. Typhimurium induces mucosal inflammation and diarrhea by
triggering specific cytokine-networks including pronounced induc-
tion of IFN-c, TNF-a, CXCL2, IL-1b, IL-17, IL-22 and
numerous other cytokines [2–4]. Although the pathogen exploits
these host responses [5,6], cytokine-signaling is essential for the
host for controlling and resolving the infection. Humans with
primary immunodeficiency (PID) are highly susceptible to
bacterial infections [7]. One key cytokine controlling bacterial
infection, i.e. salmonellosis, is interferon gamma (IFN-c). It
controls the systemic spread of the pathogen and contributes to
mucosal inflammation [3,8–11].
IFN-c is produced in the gut and spleen soon after infection
[10–16], mainly by NK, NKT, CD4
+ and CD8
+ T cells [17], and
boosts microbial killing by macrophages [18–21]. At systemic sites
IFN-c helps to limit bacterial expansion at all stages of the
Salmonella infection [16,22–25]. Neutralizing anti-IFN-c antibodies
exacerbate the disease [16,24] and cause relapses in chronically
infected mice [23]. Accordingly, IFN-cR
-/- mice are hyper-
susceptible to systemic S. Typhimurium infection [25,26].
Mucosal S. Typhimurium infections are also affected by IFN-c.
In the streptomycin mouse model, IFN-c deficiency was shown to
result in reduced gut tissue inflammation, reduced T-cell
infiltration and reduced induction of MPO, TNFa, CXCL9,
CXCL10 MHC-II and VCAM-1 [9,10,27]. This is supported by
data from PARP1
-/- mice which show a delayed IFN-c response
and delayed cecal inflammation [11]. However, besides these
global effects, it has remained unclear which cell types of the
infected mucosa might be affected by the IFN-c response. In this
paper, we have focused in particular on goblet cells.
Goblet cells are mucin-producing specialized epithelial cells in
the small and the large intestine. Mucins, a class of high molecular
weight glycoproteins [28], are stored within vacuoles. During
homeostasis, continuous secretion occurs at the apical site where
the mucins form the mucus gel [29,30] which (partially) protects
against Yersinia enterocolitica [31], Shigella flexneri [32] and Citrobacter
rodentium [33].
The major secreted mucin is Muc2 [29,34]. This glycoprotein is
constantly secreted into the lumen where it helps to form a
protective gel-like structure. In the colon, this 150 mm thick
structure consists of a loose outer layer providing nutrients to
commensals, thus fortifying colonization resistance [35], and a
tightly packed inner layer, serving as an anchor for sIgA and
prohibiting bacterial access to the epithelial surface [33,36–39].
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secretion is accelerated, thus reducing the number of mucin-filled
vacuoles present in the affected epithelium [40–42]. In helminth
infections, mucin secretion by the intestinal epithelium is
controlled by the Th2 cytokines IL-4 and IL-13 [43–45].
However, the regulation of mucin secretion in response to other
enteropathogens is still not fully understood [46].
Here, we analyzed mucosal responses coordinated by IFN-cR-
signaling during acute bacterial mucosal infection. For this
purpose, we used the streptomycin mouse model for S.
Typhimurium diarrhea. This revealed that IFN-cR-signaling
influences at least two different responses of the infected mucosa,
namely restriction of pathogen loads in the mucosal tissue, as well
as the generation of mucus-filled vacuoles by goblet cells and
mucus release into the gut lumen.
Materials and Methods
Ethics Statement
All animals were handled in strict accordance with good animal
practice as defined by the relevant national and/or local animal
welfare bodies, and all animal work was approved by the
appropriate committee (Kantonales Veterina ¨ramt Zu ¨rich, Zu ¨rich
Switzerland, license number 201/2007).
Bacterial strains
SL1344 was utilized as wild type Salmonella Typhimurium [47] .
For infection, bacteria were cultured in 0.3 M NaCl for 12 h at
37uC and sub-cultivated for 4 hrs as described previously [48]. For
detection of bacteria within mucosal tissue, bacteria harbored the
reporter plasmid pM973 (ssaH promoter fused to gfp; [49]).
Mice
IFN-cR
-/- (B6.129S7-Ifngr1
tm1Agt/J; C57BL/6 background;
[50]), C57BL/6ptprc
a (congenic marker Ly5.1
+; [51]) and
C57BL/6ptprc
b (congenic marker Ly5.2
+; originally from Charles
River) as well as IFN-cR
+/2 mice (F1 crossing of IFN-cR
-/- and
C57BL/6ptprc
b mice) were kept and bred under specified
pathogen free (SPF) conditions at the RCHCI, ETH Zu ¨rich.
IFN-cR
-/- (129-Ifngr
tm1Agt/J; 129Sv/Ev background; [50]) and
129Sv/Ev mice were bred and obtained from the research
contract company (Fu ¨llinsdorf, Switzerland). For experiments
mice were age (8–12 weeks old) and sex matched and treated as
described previously [52,53]. Briefly, mice were pre-treated with
streptomycin (1 dose, 25 mg/animal, by gavage). 24 h later mice
were sacrificed (0 dpi) or infected with 5610
7 colony forming unit
(cfu) by gavage. Infections were performed for 24 h (1 dpi) and
48 h (2 dpi) as well as 96 h (4 dpi). Bacterial loads of gut lumen
content, mesenteric lymph nodes (MLN), liver and spleen were
determined by plating [53].
Generation of Bone marrow chimeras
The generation of bone marrow chimeras has been described
before [2,53] and has been approved by the Swiss authorities
(license 201/2007 Kantonales Veterina ¨ramt Zu ¨rich). In brief,
donor mice were euthanatized and bone marrow from femur,
tibia, brachium and pelvis were extracted. Recipient mice were c-
irradiated (950 rad) and reconstituted with 3610
7 to 6610
7 bone
marrow cells intravenously. Animals were checked regularly and
received drinking water with 0,48% Borgal (24% solution;
Intervet) for 3 weeks. After 8 weeks, reconstitution efficiency was
controlled by FACS (Ly5.1/CD45.1, Ly5.2/CD45.2) on spleen
and/or blood. In all bone marrow chimeras, the reconstitution
efficiency surmounted 90%.
Histopathological evaluation
Tissues were embedded in OCT (Sakura, Torrance, CA) and
snap-frozen in liquid nitrogen. 5 mm cryosections were stained
with haematoxylin and eosin. Evaluation was done by a
pathologist in a sample-identity-blinded manner, and considered
edema, polymorphonuclear (PMN) cell infiltration, loss of goblet
cells and epithelium disruption, yielding a score of inflammation
between 0–13 points as described recently [2,52].
Mucosal tissue colonization
S. Typhimurium harbored a reporter plasmid consisting of the
ssaH promoter fused to gfp (pM973; [49]). For evaluating of tissue
invaded S. Typhimurium, cecum tissue was PFA fixed and stored
as descripted before [53]. 20 mm cryosections were stained with
Armenian hamster a-ICAM-I/CD54 (clone 3E2) (1:100; Becton
Dickson), DAPI (1:1000, Sigma-Aldrich), Cy3-conjugated goat a–
Armenian hamster IgG (1:100, Jackson ImmunoResearch Labo-
ratories) and AlexaFluor647 conjugated phalloidin (1:100, Molec-
ular Probes) [42,53]. To evaluate the average number of invaded
bacteria in the epithelium and lamina propria, 3 tissue sections per
mouse were counted.
Immunofluorescence staining
For Ki67- and CD54-staining, 7 mm cryosections were made
from OCT-embedded snap-frozen tissue. Triton pre-treatment
and staining procedures have been described previously [2,54]:
polyclonal rabbit a-Ki67 (1:100; Abcam), Armenian hamster a-
ICAM-I/CD54 (clone 3E2) (1:100; Becton Dickson), FITC-
conjugated a-rabbit IgG and Cy3-conjugated goat a–Armenian
hamster IgG (each 1:100, Jackson ImmunoResearch Laborato-
ries), TO-PRO 3 iodide (1:6000, Molecular Probes) and Alexa-
Fluor350 conjugated phalloidin (1:100, Molecular Probes). The
mucus staining with the lectin UEA-1 has been described recently
[42]. 7 mm PFA fixed cryosections were stained with rhodamine
conjugated UEA-1 (1:100, Reactolab), TO-PRO 3 Iodide (1:6000,
Molecular Probes) and Alexa488 conjugated phalloidin (1:100,
Molecular Probes). The staining with the lectin WGA was done
similarly to UEA-1: AlexaFluor647 conjugated WGA (1:100,
Molecular Probes), SytoxGreen (1:10000, Molecular Probes) and
TRITC conjugated phalloidin (1:100, Molecular Probes) were
used. For the quantification of WGA
+ cells, we evaluated three
stained 7 mm tissue sections from 5 mice per group (three 20x
images per section). Bars represent the mean number of WGA
+
cells (+/2 standard error of mean) in each experimented group.
Images were taken with a Zeiss Axiovert 200 m inverted
microscope equipped with an Ultraview confocal head (PerkinEl-
mer) and a Plan Neofluoar x20 objective with an aperture setting
of 0.55 (Zeiss).
Muc2
+ cells
7 mm cryosections of snap-frozen tissue were stained with a
polyclonal rabbit antiserum PH497 a-GpA Muc2 [55] that stains
the non-glycosylated Muc2-precursors of the goblet cells. As a
secondary antibody we employed FITC-conjugated a-rabbit IgG
(1:100, Jackson ImmunoResearch Laboratories) and DAPI
(1:1000, Sigma-Aldrich). 3 mice were analyzed per group. Each
bar represents the mean number of Muc2
+ cells (+/2 standard
error of mean) of the 20x optical field of three different sections per
mouse.
RT PCR analysis
The cecum tissue was washed in PBS (4uC), submerged in
600 ml RNAlater-buffer (RNeasy Mini Kit, Qiagen). RNA was
IFN-cR regulates mucosal goblet cells
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DNase kit (Qiagen), M-MLV reverse Transcriptase RNase H
Minus (Promega) and RNasin Plus (Promega). qPCR analysis of
Gapdh (GGC TGC CCA GAA CAT CAT CCC TGC AT; ACG
TCA GAT CCA CGA CGG ACA CAT TGG), cxcl2 (AGG CTC
CTC CTT TCC AGG TC; CCC CCT GGT TCA GAA AAT
CA) and muc2 (CAA AGG CCT CAC CAC CAA GC; GCG
TGG CAC TGG GAG AAT AG) was performed via the FastStart
Universal SYBR Green Master (Roche, Switzerland). Relative
cxcl2 and muc2 mRNA levels (2
-DDCt) were normalized using the
values for Gapdh. Cycling parameters were 94uC (15 s), 60uC
(30 s), 72uC (30 s) in a RotorGene 3000 cycler (Corbett Research,
Cambridgeshire, UK).
Statistical Analysis
Statistical Analysis has been performed using the exact Mann-
Whitney U-test and the software GraphPad Prism 5. For the
Muc2
+ cell evaluation, the unpaired t-test (two-tailed) has been
used. Values of p,0.05 were considered as significantly different
between two groups.
Results
Increased number of mucus-filled goblet cells in the
infected mucosa of IFN-cR
-/- mice
Earlier work had established that acute S. Typhimurium
infection leads to a dramatic depletion of mucus-filled goblet cells
from the cecal mucosa [52,53]. Pilot experiments indicated that
this phenotype was much less pronounced in IFN-cR deficient
mice. This was observed in different genetic mouse backgrounds
and at different times after infection (Figure S1).
To systematically analyze the role of interferon gamma receptor
(IFN-cR) signaling in acute S. Typhimurium colitis, we employed
the streptomycin mouse model. Streptomycin pre-treated IFN-
cR
-/- mice ([50] n=8 mice), C57BL/6 controls (n=5 mice; black
circles) and IFN-cR
+/2 littermate control mice (n=3 mice; grey
circles) were infected with wild type S. Typhimurium SL1344
(pM973; 5610
7 cfu by gavage, [49]) as described in Materials and
Methods. The pathogen harbored the GFP reporter plasmid
pM973 which drives gfp-expression soon after S. Typhimurium has
entered into the gut tissue. This allows enumerating pathogen
Figure 1. Mucosal S. Typhimurium infection in IFN-cR
-/- and isogenic control mice. IFN-cR
-/- mice (C57BL/6 background; open symbols),
C57BL/6 controls (closed black symbols) and IFN-cR
+/2 control mice (closed grey symbols) were pre-treated with streptomycin and infected for 1 day
(1 dpi) or 2 days (2 dpi) with S. Typhimurium (SL1344 pM973; Material and Methods). We analyzed colonization levels in the gut lumen (A), the MLNs
(B), the livers (C), the spleens (D) and the mucosal tissues (E; red = lamina propria; blue = epithelial cells). Data point color code: closed symbols (red,
dark blue) = C57BL/6 mice; closed symbols (orange, light blue) = IFN-cR
+/2 control littermates; open symbols (red, dark blue) = IFN-cR
+/2 mice.
*: p,0.05.
doi:10.1371/journal.pone.0022459.g001
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PLoS ONE | www.plosone.org 3 July 2011 | Volume 6 | Issue 7 | e22459Figure 2. Mucosal pathology of S. Typhimurium infected IFN-cR
-/- mice. Infected animals from Fig. 1 (IFN-cR
-/- mice, open symbols; C57BL/6
control, closed black symbols; and IFN-cR
+/2 control mice, closed grey symbols) as well as streptomycin pre-treated non-infected animals (0 dpi) were
analyzed (A–F). (A,B) HE-stained tissue sections from wt C57BL/6 controls and IFN-cR
-/- mice at day 2 p.i.. (C) Inflammation of the cecal mucosa. (D)
The number of goblet cells harboring mucus-filled vacuoles was analyzed using HE-stained tissue sections. (E) WGA-AlexaFluor647 staining for mucin
(incl. mucus filled vacuoles, secreted mucins). (F) Quantitative analysis of the number of goblet cells which harbor mucus-filled vacuoles as
determined by WGA-AlexaFluor647 fluorescence microscopy (see E). G
HE: mucus-filled goblet cell vacuoles detected in HE-stained tissue sections.
G
WGA: mucin-filled goblet cell vacuoles detected in tissue sections stained with the lectin WGA-AlexaFluor647. (G, H). Quantitative real time PCR
analysis of cxcl2 and muc2 expression. RNA samples from IFN-cR
-/- mice (open symbols), C57BL/6 control, (closed black symbols) and IFN-cR
+/2
control mice (closed grey symbols) were selected from the experiment shown above. mRNA expression levels were normalized to Gapdh (Materials
and Methods). *: p,0.05; ns: not statistically significant. Black line: median. Errors bars (F): standard error of mean; bar =100 mm.
doi:10.1371/journal.pone.0022459.g002
IFN-cR regulates mucosal goblet cells
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sacrificed at 1 day or 2 days post infection and analyzed for
pathogen loads in the cecum lumen, the mesenteric lymph nodes
(MLN), the liver and the spleen (Fig. 1A–D). S. Typhimurium
efficiently colonized the intestinal lumen in all groups of mice
(Fig. 1A). The MLN were colonized by day 1 p.i. and pathogen
loads did not differ significantly between the control group
consisting of wild type and IFN-cR
+/2 littermates and the IFN-
cR
-/- mice (approx. 10
3 cfu/ MLN; p$0.05; Fig. 1B). However,
during the next 24 h, MLN pathogen loads increased more slowly
in the control mice than in the knockout animals (approx. 10
5 vs.
10
4 cfu/ MLN; p,0.05). Similarly, the pathogen loads in the liver
and the spleen of the IFN-cR
-/- mice were significantly increased
by day 2 p.i. (p,0.05; Fig. 1C,D; open symbols). This was in line
with earlier data and indicated that IFN-cR-signaling contributes
to controlling infection at systemic sites [16,22–25].
Next, we analyzed the pathogen colonization of the cecal
mucosa. At day 1 p.i., we detected equivalent pathogen loads in
the cecal lamina propria of wild type (red closed symbols), the IFN-
cR
+/2 (orange closed symbols) and the IFN-cR
-/- mice (open red
symbols; p$0.05; approx. 20–100 bacteria per tissue section;
Fig. 1E). However, by day 2 p.i., pathogen loads had increased
significantly in the lamina propria of the IFN-cR
-/- mice, but not
in the control animals (p,0.05; Fig. 1E). Similarly, in the epithelial
cells the IFN-cR-deficiency had no effect at day 1 p.i., but
pathogen loads increased significantly in the IFN-cR
-/- mice by
day 2 p.i. (p,0.05; Fig. 1E, blue symbols). This indicated that
IFN-cR-signaling helps controlling mucosal tissue infection at
early time points post infection.
Then, we analyzed the role of IFN-cR-signaling with respect to
gut inflammation and the goblet cell phenotype, as observed in the
experiments above (Fig. 2A–H). In the absence of infection, IFN-
cR
-/- and wt control mice displayed no signs of mucosal
pathology, equivalent numbers of mucus filled goblet cells and
equivalent mRNA levels for muc2, the gene encoding the key
secreted goblet cell mucin (p$0.05; Fig. 2C,D,F,H; 0 dpi). Upon
infection, all mice developed pronounced mucosal inflammation
(Fig. 2A–C). At day 1 p.i., cecal pathology (but not cxcl2-
expression; Fig. 2G) of IFN-cR
-/- mice was slightly reduced
compared to wild type and IFN-cR
+/2 littermates. This is in line
with previous reports [9,11]. However, by day 2 p.i. knockout and
wild type mice reached equivalent levels of mucosal inflammation.
In line with a large body of previous work (e.g. [42,52]), the wt
mice showed severely reduced numbers of mucus-filled goblet cells
after infection. In contrast, the cecal mucosa of infected IFN-cR
-/-
mice retained much higher numbers of mucus-filled vacuoles
(Fig. 2A,B; see marked G
HE vacuoles in Fig. 2B, right panel). This
confirmed date presented, above (Figure S1).
WGA-immunofluorescence microscopy confirmed this pheno-
type (Fig. 2E; see marked G
WGA vacuoles in the right panel; [42]).
The wheat germ agglutinin (WGA) recognizes glyco-epitopes of
the mature, modified mucins stored within the mucus-filled
vacuoles of goblet cells. Via WGA-staining we confirmed the
presence of higher numbers of mucin-filled goblet cells in the cecal
mucosa of IFN-cR
-/- compared to C57BL/6 mice and IFN-cR
+/2
littermates (p,0.05; Fig. 2F). Finally, real time PCR analyses
demonstrated that this was not attributable to changes in muc2
gene expression (p$0.05; Fig. 2G,H). In conclusion, these data
suggested that IFN-cR-signaling affects the kinetics of mucin
release by goblet cells in the infected cecal mucosa.
IFN-cR-signaling in the stromal compartment controls
goblet cell function
To determine whether the IFN-cR-mediated control of the
goblet cells is conferred by the stromal or the bone marrow derived
compartment, we generated bone marrow chimeras (BM chime-
ras) and challenged the animals in the streptomycin mouse model.
We generated three types of BM chimeric animals: a) "B6/IFN-
cR" chimeras by reconstituting C57BL/6 mice (Ly5.1 marker)
with IFN-cR
-/- (Ly5.2 marker) bone marrow; b) "IFN-cR/B6"
chimeras by reconstituting IFN-cR
-/- mice (Ly5.2 marker) with
C57BL/6 (Ly5.1 marker) bone marrow; c) "B6/B6" chimeras by
reconstituting C57BL/6 mice (Ly5.2 marker) with C57BL/6
(Ly5.1 marker) bone marrow as described in Materials and
Methods.
The BM chimeric mice were pre-treated with streptomycin and
infected with wild type S. Typhimurium SL1344 (pM973; n=9 to
12 mice per group; 5610
7 cfu by gavage). Mice were sacrificed at
day 2 p.i. and we analyzed pathogen loads in the cecum lumen,
the mesenteric lymph nodes (MLN), the liver and the spleen
(Fig. 3A–D). S. Typhimurium efficiently colonized the intestinal
lumen in all groups of mice (Fig. 3A). The "B6/IFN-cR" chimeras
harbored significantly higher pathogen loads in the MLN, the liver
and the spleen than the "IFN-cR/B6" chimeras or the "B6/B6"
control chimeras (p,0.05; Fig. 3B,C,D). This indicated that in
cells of the BM-derived compartment (i.e. macrophages, PMNs,
DCs) IFN-cR-signaling is essential for controlling pathogen spread
to systemic sites, while IFN-cR-signaling in stromal cells is
dispensable.
Next, we analyzed the infection of the cecal mucosa. Equivalent
pathogen loads were detected in the epithelial cells from all three
groups of mice (p$0.05; Fig. 3E, blue symbols). In contrast, the
lamina propria pathogen loads were significantly higher in the
"B6/IFN-cR" chimeras, than in the "IFN-cR/B6" chimeras or the
"B6/B6" controls (p,0.05; Fig. 3E, red symbols). Thus, IFN-cR-
signaling in cells of the BM-derived compartment (i.e. macro-
phages, PMNs, DCs) is required normally to control pathogen
burdens in the cecal mucosa, while IFN-cR-signaling in stromal
cells does not affect pathogen loads.
Finally, we evaluated mucosal inflammation. Gut inflammation
was slightly more pronounced in the "B6/IFN-cR" chimeras than
in the "IFN-cR/B6" chimeras or the "B6/B6" control chimeras
(p,0.05; Fig. 4A,B). This was well in line with the increased
lamina propria burdens observed in the "B6/IFN-cR" chimeras
(Fig. 3E). Then we enumerated the goblet cells harboring mucus-
filled vacuoles. The gut tissue of "B6/IFN-cR" chimeras harbored
the lowest number of these cells (p,0.05; Fig. 4C). This was in line
with the stronger mucosal inflammation and the increased lamina
propria burdens observed in these animals. Interestingly, the
"IFN-cR/B6" chimeras harbored significantly more mucus filled
goblet cells than the "B6/IFN-cR" chimeras or the "B6/B6"
Figure 3. Mucosal S. Typhimurium infection in IFN-cR
-/- bone marrow chimeras and IFN-cR
+/+ controls. We generated bone marrow
chimeras (BM chimeras) and challenged the animals with S. Typhimurium (SL1344; harboring pM973) in the streptomycin mouse model for 2 days (A-
E). Types of BM chimeric animals generated: "B6/IFN-cR" [C57BL/6 mice (Ly5.1 marker) reconstituted with IFN-cR
-/- (Ly5.2 marker) bone marrow;
circles], "IFN-cR/B6" [IFN-cR
-/- mice (Ly5.2 marker) reconstituted with C57BL/6 (Ly5.1 marker) bone marrow; squares] and "B6/B6" [C57BL/6 mice (Ly5.2
marker) reconstituted with C57BL/6 (Ly5.1 marker) bone marrow; triangles] . We analyzed colonization levels in the gut lumen (A), the MLNs (B), the
livers (C), the spleens (D) and the mucosal tissues (E; red = lamina propria; blue = epithelial cells). *: p,0.05. Black line: median. n.s.: not significant
(p$0.05). Stippled line: minimal detectable value.
doi:10.1371/journal.pone.0022459.g003
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disease were equivalent between the "IFN-cR/B6" chimeras and
the "B6/B6" controls (p$0.05; Figs. 3 and 4). In conclusion, these
data indicated that IFN-cR-signaling in stromal cells modulates
mucus secretion by goblet cells.
To further substantiate this observation, we evaluated the
infected gut tissues by immunofluorescence microscopy. Besides
wheat germ agglutinin (WGA), the lectin Ulex europaeus agglutinin-1
(UEA-1) can also recognize glyco-epitopes of the mature, modified
mucins stored in goblet cells. Secreted mucins on the epithelial
surface and within the gut lumen are also stained by these two
lectins (Fig. 4D; [42]). Staining with these markers verified that the
mucosa of "IFN-cR/B6" chimeras harbored large numbers of
goblet cells with mucus-filled vacuoles (Fig. 4D). Control stains for
the lamina propria marker CD54 (ICAM-I; stains lamina propria
and most cells of the gut associated immune system) or the
proliferation marker Ki67 (a measure of tissue regeneration; see for
example [2,54]) yielded equivalent results for the "IFN-cR/B6" and
the "B6/IFN-cR" chimeras (Fig. 4E). These data corroborated that
goblet cell function is directly modulated by IFN-cR-signaling, e.g.
bycontrollingthegenesis ofthemucus-filled vesiclesorbytriggering
mucus release. Thus, IFN-cR-signaling is required on hematopoi-
etic cells to control pathogen burden, and on the stromal
compartment to facilitate increased mucus secretion.
The density of goblet cells is not affected in IFN-cR-
deficient mice
Finally, we have addressed whether goblet cell function is affected
at the level of mucus secretion. Alternatively, the genesis or
maintenance of goblet cells might be affected in IFN-cR-deficient
mice. The latter might be suggested by recent findings on the role of
IFN-c in regulating intestinal epithelial homeostasis and function
[56,57]. In order to address this issue, we employed immunoflu-
orescence microscopy and a Muc2-specific antibody. This antibody
recognizes specifically an epitope of immature mucin which is
always located within goblet cells, but which is not secreted. Thus,
the a-Muc2-antibody allows staining of all goblet cells, synthesizing
or storing Muc2, independent of the presence or absence of mucus-
filled vacuoles [38,42]. Using the a-Muc2-antibody, we detected
equivalent numbers of goblet cells in the cecal mucosa of all BM
chimeras ("B6/IFN-cR", "IFN-cR/B6" and "B6/B6; gray shading;
p$0.05; Fig. 5CD). We also analyzed IFN-cR
-/- mice and control
wild type C57BL/6 mice as well as IFN-cR
+/2 littermates prior to
infection (0 dpi) and at day 1 p.i.. However, no difference in the
numberofMuc2
+cellscouldbedetectedbetweenanyofthegroups,
analyzed (Fig. 5 A,B,D). In addition the number of Muc2
+ cells was
also not affected by the procedures for generating the BM chimeras
as judged by comparison with non-irradiated groups (C57BL/6,
IFN-cR
+/2, IFN-cR
-/- mice at day 0 p.i. and 1 p.i.; p$0.05;
Fig. 5D). These data confirmed that goblet cell numbers were not
affected by IFN-cR-deficiency. Rather, IFN-cR-signaling seems to
drive the secretion of goblet cell content.
Discussion
Interferon gamma is a key cytokine coordinating immune
defense against infection. Earlier work had established that IFN-c
contributes to acute mucosal inflammation in the streptomycin
model for Salmonella diarrhea [9]. This is confirmed by our findings
in IFN-cR
-/- mice (Fig. 2C; 1 day p.i.) and the delayed gut
inflammation at 8h p.i. in PARP1
-/- and IFN-c
-/- mice ([11],
Hapfelmeier and Hardt, unpublished observations). Here, we have
extended these studies by demonstrating that IFN-cR-signaling
affects the acute mucosal disease in at least two ways, i.e. by
restricting pathogen loads in the lamina propria and by controlling
mucus accumulation/secretion by goblet cells. The former
requires IFN-cR-signaling in BM-derived cells, presumably
macrophages, DCs and/or PMNs, while the latter depends on
IFN-cR-signaling in stromal cells. Thus, during the acute S.
Typhimurium infection, different compartments of the intestinal
mucosa are functionally coordinated by IFN-cR-signaling.
How does IFN-cR-signaling affect mucosal colonization by S.
Typhimurium? Earlier work had established that IFN-cR-
signaling is essential for controlling the systemic infection by
numerous pathogens, including S. Typhimurium ([3,16,22-25] ;
this work). This is attributable to the pronounced up-regulation of
bactericidal capacities in IFN-c exposed macrophages and their
key role in pathogen elimination at systemic sites. In the intestinal
mucosa, S. Typhimurium resides in macrophages, but also in other
cell types like PMNs, DCs and epithelial cells/enterocytes [2,49].
Therefore, it was previously unclear whether IFN-c would have a
similar effect on pathogen control as observed at systemic sites.
Our work establishes that this is indeed the case. In IFN-cR
-/-
mice and BM-chimeric mice lacking IFN-cR in BM-derived cells,
S. Typhimurium can enter the cecal tissue and colonize the lamina
propria, without being restricted. Interestingly, increased lamina
propria colonization has been observed previously in Cybb/Nos2
knockout mice [58]. These mice lack NADPH oxidase 2 and
inducible NO-synthase, two enzymes required for the production
of oxygen and nitrogen species which are key anti-microbial agents
produced by macrophages and by PMNs [59]. This suggests that
IFN-cR-signaling induces these antimicrobial defenses of mucosal
phagocytes. Identifying the key cell types and the remaining
elements of the signaling pathways eliciting Cybb/Nos2-responses
in the intestinal mucosa will be an interesting topic for future
research.
The pathogen loads in the cecal epitheliumwerealso increased in
the IFN-cR
-/- mice (Fig. 1E, day 2 p.i.; open blue symbols). There
are at least three different explanations for this observation: 1)
Reduced mucus secretion might lower the mucus mediated
bacterial clearance from the epithelial surface and result in
increased pathogen invasion rates from the gut lumen; 2) the
IFN-cR
-/- epithelium might fail to restrict pathogen growth within
this cell type; 3) Increased pathogen loads in the IFN-cR
-/- lamina
propria might lead to increased rates of pathogen invasion from the
basolateral side. This might be similar to the basolateral epithelium
invasion by Shigella flexneri, another enteropathogenic bacterium
[60]. Interestingly, IFN-cR-deficiency in the stromal- or the BM-
derived compartment alone did not increase epithelial pathogen
loads (Fig. 3E, blue circles, blue squares). This suggests that multiple
mechanisms involving BM-derived and stromal cells cooperate in
order to restrict pathogen loads in the intestinal epithelium.
During infection, IFN-cR
-/- goblet cells display strikingly high
numbers of mucus-containing vacuoles. These numbers are
Figure 4. Mucosal pathology and mucus-filled vacuoles in the mucosa of S. Typhimurium-infected IFN-cR
-/--bone marrow chimeras.
We analyzed the cecum mucosa of S. Typhimurium-infected BM chimeras shown in Fig. 3. (A), HE-stained gut tissue sections. (B) Mucosal tissue
pathology. (C) Quantitative analysis of the number of mucus vacuoles in the cecal mucosa of infected BM chimeras as determined from HE-stained
tissue sections. (D) UEA-1-rhodamine or WGA-AlexaFluor647 staining of glycoconjugates /mucins. (E) Staining of the cell-proliferation marker Ki67 and
the lamina propria marker CD54 (E). *: p,0.05; Black line: median. n.s.: not significant (p$0.05). Bar =100 mm.
doi:10.1371/journal.pone.0022459.g004
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PLoS ONE | www.plosone.org 8 July 2011 | Volume 6 | Issue 7 | e22459Figure 5. Mucus-filled goblet cell vacuoles in the cecal mucosa of S. Typhimurium infected BM chimeras, C57BL/6 controls, IFN-cR
+/2
mice and IFN-cR
-/- animals. Cecum tissues of BM chimeras from Fig. 3 and 4 (2 dpi), as well as cecum tissue from C57BL/6 controls, IFN-cR+/2
littermates and IFN-cR-/- mice from Fig. 2 (0 dpi and 1 dpi) were analyzed. (A–C) Immunofluorescence microscopy images of cecal tissue sections from
non-infected controls (A) and mice at days 1 p.i. (B) and day 2 p.i. (C). Green, anti-Muc2-antibody staining; The Muc2-specific antibody recognizes an
epitope of immature mucin, located within goblet cells, but absent from secreted Muc2. red: actin (phalloidin staining); blue: DNA (DAPI staining). (D)
Quantitative analysis of the number of goblet cells which harbor mucus-filled vacuoles as determined by Muc2 fluorescence microscopy. No significant
differences were observed when compared to non-infected C57BL/6 mice (p$0.05). Errors bars (D): standard error of mean. Bar =100 mm.
doi:10.1371/journal.pone.0022459.g005
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PLoS ONE | www.plosone.org 9 July 2011 | Volume 6 | Issue 7 | e22459equivalent to those observed under steady state conditions in the
healthy mucosa. Based on this observation, it seems most likely
that IFN-c, which is triggered during the first 6h of the gut
infection [11], triggers the release of these vacuolar contents.
However, we cannot rule out that IFN-c may affect other
parameters of mucus-vacuole formation, like vacuole size or the
rate of vacuole formation. Future work will have to address this
issue.
Mucus is an important defense against mucosal pathogens. For
example, muc2
-/- mice are susceptible to chronic mucosal
inflammation elicited by the normal gut flora and to lethal
infectious colitis by Citrobacter rodentium [33,39]. However, mucin
gene expression, mucus release and cytokine control seem to vary
significantly between different infection models. For example,
cholera toxin is known to elicit mucus secretion and secretion can
be inhibited by IFN-c, as shown in a HT29 Cl.16E human tissue
culture model [61]. This differs from our findings in the murine
Salmonella diarrhea model, where IFN-c-signaling is required for
mucus release. We do not know whether this difference is
attributable to the different nature of the two models (tissue culture
cell line vs. in vivo). Alternatively, different secretion stimuli
(Salmonella infection vs. cholera toxin etc.) might differ in their
positive/negative modulation by IFN-c. Also, we cannot exclude
species-specific differences in the control of mucin release from
goblet cells between humans and mice.
Shekels at al. [62] used a mouse gut infection model to analyze
the effect of nematode infection with Trichinella spiralis on mucosal
muc2 and muc3 mRNA levels as well as mucus vacuole size/
numbers in the small intestine. Interestingly, in this nematode
model, the mucin mRNA levels and the number of goblet cells
harboring mucus-filled vacuoles increased in response to infection.
The increase was independent of IFN-c signaling, suggesting that
IFN-c does not affect mucin-release in the nematode infection
model. This is quite different from our findings in the infected
cecum tissue of Salmonella infected mice. Here, infection does not
affect mucin mRNA levels, but enhances mucin excretion from
goblet cells. The latter is a hallmark of the mucosal S.
Typhimurium infection [52]. Similar observations have been
made in Listeria monocytogenes-infected rabbit ileal loops [63].
Nevertheless, even closely related pathogens like ‘‘atypical’’ and
‘‘typical’’ enteropathogenic E. coli, can differ significantly in their
effects on mucin expression and secretion [64]. Thus, mucin
expression and release might be regulated in a pathogen-specific
fashion. Such pathogen-specific responses may be of great
importance for understanding the host range of different mucosal
pathogens and the susceptibility of particular hosts to pathogen-
inflicted disease.
We found that IFN-cR-signaling coordinates multiple aspects of
mucosal defense, including pathogen restriction in the gut tissue
and goblet cell function. Clearly, other cytokines are also involved.
Moreover, the epithelial cells of the infected mucosa can produce
and secrete anti-microbial peptides and express high levels of the
polymeric Ig receptor, a transporter mediating secretory IgA
secretion into the gut lumen [65,66]. Interestingly, this is also
controlled by IFN-c-signaling [9,67]. Most likely, mucus secretion,
antimicrobial peptides and sIgA cooperate to protect the intestinal
mucosa. It will be an important topic for future research to unravel
how these defenses are coordinated and how this confers efficient
protection against gut pathogens.
Supporting Information
Figure S1 Pilot experiments showing high numbers of
goblet cells with mucus filled vacuoles in the cecal
mucosa of infected IFN-cR
-/- mice. IFN-cR-/- mice
(C57BL/6 background) and C57BL/6 control mice were pre-
treated with streptomycin and infected for 1 day (A; 1dpi) and 2
days (B; 2dpi) with S. Typhimurium (SL1344; Material and
Methods). The cecal tissue of IFN-cR
-/- mice on C57BL/6
background (right panel) seemed to harbor more mucus-filled
goblet cells at 1dpi (A) and 2dpi (A) compared to C57BL/6 control
mice (left panel). IFN-cR
-/- mice (129Sv/Ev background) and
129Sv/Ev control mice were pre-treated with streptomycin and
infected for 4 days (C; 4dpi) with S. Typhimurium (SL1344;
Material and Methods). Again, the cecal mucosa of the IFN-cR
-/-
animals (right panel) harbored more mucus-filled goblet cells in the
cecal tissue compared to 129Sv/Ev control mice (left panel). GHE:
mucus-filled goblet cell vacuoles detected in HE-stained tissue
sections. Bar =100 mm.
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